AALR3 Stock Overview
Alliança Saúde e Participações S.A. provides diagnostic medicine services in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Alliança Saúde e Participações S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$8.77 |
| 52 Week High | R$24.32 |
| 52 Week Low | R$6.15 |
| Beta | 0.91 |
| 1 Month Change | 23.70% |
| 3 Month Change | 0% |
| 1 Year Change | -61.37% |
| 3 Year Change | -6.60% |
| 5 Year Change | -39.68% |
| Change since IPO | -54.32% |
Recent News & Updates
Recent updates
Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around
Aug 17
Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching
Jul 08Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?
May 28What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?
Apr 05Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years
Mar 10Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?
Feb 17What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?
Jan 27
Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?
Jan 06What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?
Dec 11Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?
Aug 07Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Jul 20Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?
Jul 03Shareholder Returns
| AALR3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -9.9% | -7.2% | -5.5% |
| 1Y | -61.4% | 3.4% | 9.9% |
Return vs Industry: AALR3 underperformed the BR Healthcare industry which returned 6.3% over the past year.
Return vs Market: AALR3 underperformed the BR Market which returned 12.7% over the past year.
Price Volatility
| AALR3 volatility | |
|---|---|
| AALR3 Average Weekly Movement | 9.2% |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 8.6% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: AALR3's share price has been volatile over the past 3 months.
Volatility Over Time: AALR3's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Isabella Correa | www.allianca.com |
Alliança Saúde e Participações S.A. provides diagnostic medicine services in Brazil. Its diagnostic medicine services include diagnostic imaging tests, nuclear medicine and clinical analysis, and vaccines in the public and private sector. The company also engages in the provision of consulting, assitances, courses and lectures, and the services related to health; management of chronic diseases; scientific and technologic research and development related to diagnostic medicine; preparation, issue, publication, and distribution of newspapers, books, magazines, periodicals, and other vehicles of written communication and the dissemination of scientific knowledge; and grant and management of business franchises.
Alliança Saúde e Participações S.A. Fundamentals Summary
| AALR3 fundamental statistics | |
|---|---|
| Market cap | R$1.04b |
| Earnings (TTM) | -R$227.88m |
| Revenue (TTM) | R$1.18b |
0.9x
P/S Ratio-4.5x
P/E RatioIs AALR3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AALR3 income statement (TTM) | |
|---|---|
| Revenue | R$1.18b |
| Cost of Revenue | R$814.78m |
| Gross Profit | R$364.80m |
| Other Expenses | R$592.68m |
| Earnings | -R$227.88m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -1.93 |
| Gross Margin | 30.93% |
| Net Profit Margin | -19.32% |
| Debt/Equity Ratio | 110.7% |
How did AALR3 perform over the long term?
See historical performance and comparison